TP53 and colorectal carcinoma: Thenceforward, CRC critical genes have already been well established, 40% of the cases of CRC have a specific point mutation in KRAS, 60% have inactivating mutations or deletions of p53, and more than 60% have mutations in the APC (adenomatous polyposis coli) tumor suppressor gene.